Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
How do you manage/prevent recurrent hordeolum?
Related Questions
In a patient with isolated HLA B27+ anterior uveitis, how long would you continue immunosuppressive therapy?
How would you approach a patient who is unable to undergo the recommended ophthalmologic examinations during treatment with mirvetuximab soravtansine?
When should mitomycin intravascular chemoembolization be considered as a treatment for corneal neovascularization?
What factors influence the choice of reconstructive technique considering both oncological control and cosmetic outcomes when performing surgery for periocular melanoma?
What baseline visual testing, if any, do you recommend at diagnosis for patients with multiple sclerosis who deny visual complaints?
Is it safe to continue azathioprine in a patient with severe bilateral panuveitis (thought to be related to sarcoidosis) and benign ethnic neutropenia, given worsening neutropenia since starting the medication, or should an alternative immunosuppressive agent be considered?
How do you decide between escalating treatment with additional IOP-lowering medications versus surgical options for patients with normal tension glaucoma and progressive visual field loss despite well-controlled IOP?
When should amblyopia treatment be initiated in patients being treated for retinoblastoma?
Do you routinely recommend IV systemic antibiotic therapy in additional to intravitreal antibiotic therapy for exogenous bacterial endophthalmitis?
What would you recommend for long term management of extensive dural venous sinus thrombosis (CVST) in young females when the only provoking risk factor is combined OCP?
